nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—Danazol—Prednisone—chronic obstructive pulmonary disease	0.113	0.203	CrCrCtD
Levonorgestrel—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.0808	0.145	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.0807	0.145	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0787	0.141	CrCrCtD
Levonorgestrel—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0701	0.126	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0675	0.121	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0659	0.118	CrCrCtD
Levonorgestrel—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0419	0.282	CbGbCtD
Levonorgestrel—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0283	0.19	CbGbCtD
Levonorgestrel—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.027	0.182	CbGbCtD
Levonorgestrel—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0241	0.162	CbGbCtD
Levonorgestrel—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0141	0.0949	CbGbCtD
Levonorgestrel—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0133	0.0897	CbGbCtD
Levonorgestrel—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00174	0.0267	CbGpPWpGaD
Levonorgestrel—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00157	0.0241	CbGpPWpGaD
Levonorgestrel—ESR1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00149	0.0229	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00135	0.0208	CbGpPWpGaD
Levonorgestrel—ESR1—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.0166	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000947	0.0146	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00082	0.0126	CbGpPWpGaD
Levonorgestrel—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000796	0.0122	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00073	0.0112	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—IL1B—chronic obstructive pulmonary disease	0.000669	0.0103	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000644	0.0099	CbGpPWpGaD
Levonorgestrel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00061	0.00938	CbGpPWpGaD
Levonorgestrel—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000605	0.0093	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000567	0.00871	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000542	0.00832	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00051	0.00783	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.0005	0.00769	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.0005	0.00769	CbGpPWpGaD
Levonorgestrel—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000489	0.00752	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—TNF—chronic obstructive pulmonary disease	0.000486	0.00746	CbGpPWpGaD
Levonorgestrel—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000483	0.00742	CbGpPWpGaD
Levonorgestrel—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000473	0.00727	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.000457	0.00702	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000452	0.00695	CbGpPWpGaD
Levonorgestrel—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00044	0.00675	CbGpPWpGaD
Levonorgestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000411	0.00631	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000404	0.00621	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—HDAC2—chronic obstructive pulmonary disease	0.000401	0.00616	CbGpPWpGaD
Levonorgestrel—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000397	0.00609	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000396	0.00609	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000394	0.00605	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000393	0.00603	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000376	0.00577	CbGpPWpGaD
Levonorgestrel—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.00575	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000372	0.00572	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000365	0.00561	CbGpPWpGaD
Levonorgestrel—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000358	0.0055	CbGpPWpGaD
Levonorgestrel—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000355	0.00546	CbGpPWpGaD
Levonorgestrel—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000351	0.00539	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000348	0.00535	CbGpPWpGaD
Levonorgestrel—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000344	0.00528	CbGpPWpGaD
Levonorgestrel—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.0015	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000343	0.00527	CbGpPWpGaD
Levonorgestrel—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00149	CcSEcCtD
Levonorgestrel—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00149	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00034	0.00522	CbGpPWpGaD
Levonorgestrel—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00149	CcSEcCtD
Levonorgestrel—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00149	CcSEcCtD
Levonorgestrel—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00149	CcSEcCtD
Levonorgestrel—Cough—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00147	CcSEcCtD
Levonorgestrel—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000336	0.00147	CcSEcCtD
Levonorgestrel—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.00147	CcSEcCtD
Levonorgestrel—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000335	0.00147	CcSEcCtD
Levonorgestrel—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00147	CcSEcCtD
Levonorgestrel—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00147	CcSEcCtD
Levonorgestrel—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00147	CcSEcCtD
Levonorgestrel—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00147	CcSEcCtD
Levonorgestrel—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00146	CcSEcCtD
Levonorgestrel—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00146	CcSEcCtD
Levonorgestrel—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00146	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000333	0.00512	CbGpPWpGaD
Levonorgestrel—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00146	CcSEcCtD
Levonorgestrel—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00146	CcSEcCtD
Levonorgestrel—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00146	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00146	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00146	CcSEcCtD
Levonorgestrel—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00145	CcSEcCtD
Levonorgestrel—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00145	CcSEcCtD
Levonorgestrel—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000331	0.00508	CbGpPWpGaD
Levonorgestrel—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00144	CcSEcCtD
Levonorgestrel—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00144	CcSEcCtD
Levonorgestrel—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00143	CcSEcCtD
Levonorgestrel—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00143	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00143	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000325	0.00142	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000324	0.00498	CbGpPWpGaD
Levonorgestrel—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000324	0.00142	CcSEcCtD
Levonorgestrel—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00142	CcSEcCtD
Levonorgestrel—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00141	CcSEcCtD
Levonorgestrel—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00141	CcSEcCtD
Levonorgestrel—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.0014	CcSEcCtD
Levonorgestrel—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.0014	CcSEcCtD
Levonorgestrel—Infection—Formoterol—chronic obstructive pulmonary disease	0.000319	0.0014	CcSEcCtD
Levonorgestrel—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00138	CcSEcCtD
Levonorgestrel—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00138	CcSEcCtD
Levonorgestrel—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000316	0.00138	CcSEcCtD
Levonorgestrel—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00138	CcSEcCtD
Levonorgestrel—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00138	CcSEcCtD
Levonorgestrel—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00138	CcSEcCtD
Levonorgestrel—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00138	CcSEcCtD
Levonorgestrel—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00138	CcSEcCtD
Levonorgestrel—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00137	CcSEcCtD
Levonorgestrel—Infection—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00137	CcSEcCtD
Levonorgestrel—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00137	CcSEcCtD
Levonorgestrel—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00137	CcSEcCtD
Levonorgestrel—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.00136	CcSEcCtD
Levonorgestrel—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000308	0.00135	CcSEcCtD
Levonorgestrel—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.00135	CcSEcCtD
Levonorgestrel—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00134	CcSEcCtD
Levonorgestrel—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00133	CcSEcCtD
Levonorgestrel—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00132	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.0003	0.00461	CbGpPWpGaD
Levonorgestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000299	0.00459	CbGpPWpGaD
Levonorgestrel—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00131	CcSEcCtD
Levonorgestrel—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00131	CcSEcCtD
Levonorgestrel—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.0013	CcSEcCtD
Levonorgestrel—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.0013	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000297	0.00456	CbGpPWpGaD
Levonorgestrel—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00129	CcSEcCtD
Levonorgestrel—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00128	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00128	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000293	0.0045	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00128	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00128	CcSEcCtD
Levonorgestrel—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00127	CcSEcCtD
Levonorgestrel—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00127	CcSEcCtD
Levonorgestrel—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00126	CcSEcCtD
Levonorgestrel—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00126	CcSEcCtD
Levonorgestrel—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000288	0.00443	CbGpPWpGaD
Levonorgestrel—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00126	CcSEcCtD
Levonorgestrel—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000287	0.0044	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00125	CcSEcCtD
Levonorgestrel—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00125	CcSEcCtD
Levonorgestrel—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00125	CcSEcCtD
Levonorgestrel—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00125	CcSEcCtD
Levonorgestrel—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00125	CcSEcCtD
Levonorgestrel—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000284	0.00125	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000284	0.00436	CbGpPWpGaD
Levonorgestrel—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00124	CcSEcCtD
Levonorgestrel—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00124	CcSEcCtD
Levonorgestrel—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00123	CcSEcCtD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000281	0.00431	CbGpPWpGaD
Levonorgestrel—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00122	CcSEcCtD
Levonorgestrel—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00122	CcSEcCtD
Levonorgestrel—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00122	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00121	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00121	CcSEcCtD
Levonorgestrel—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00121	CcSEcCtD
Levonorgestrel—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00121	CcSEcCtD
Levonorgestrel—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00121	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00121	CcSEcCtD
Levonorgestrel—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.0012	CcSEcCtD
Levonorgestrel—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.0012	CcSEcCtD
Levonorgestrel—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000274	0.0012	CcSEcCtD
Levonorgestrel—Pain—Formoterol—chronic obstructive pulmonary disease	0.000274	0.0012	CcSEcCtD
Levonorgestrel—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.0012	CcSEcCtD
Levonorgestrel—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000274	0.0012	CcSEcCtD
Levonorgestrel—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.00418	CbGpPWpGaD
Levonorgestrel—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000271	0.00119	CcSEcCtD
Levonorgestrel—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000271	0.00119	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.00416	CbGpPWpGaD
Levonorgestrel—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00118	CcSEcCtD
Levonorgestrel—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00118	CcSEcCtD
Levonorgestrel—Pain—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00118	CcSEcCtD
Levonorgestrel—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.00117	CcSEcCtD
Levonorgestrel—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00117	CcSEcCtD
Levonorgestrel—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00117	CcSEcCtD
Levonorgestrel—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00116	CcSEcCtD
Levonorgestrel—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00116	CcSEcCtD
Levonorgestrel—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00116	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000264	0.00406	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00115	CcSEcCtD
Levonorgestrel—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.00115	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00115	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00115	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00115	CcSEcCtD
Levonorgestrel—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00114	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000261	0.00401	CbGpPWpGaD
Levonorgestrel—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00113	CcSEcCtD
Levonorgestrel—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00113	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00113	CcSEcCtD
Levonorgestrel—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00112	CcSEcCtD
Levonorgestrel—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00112	CcSEcCtD
Levonorgestrel—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00111	CcSEcCtD
Levonorgestrel—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00111	CcSEcCtD
Levonorgestrel—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00111	CcSEcCtD
Levonorgestrel—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00111	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000253	0.00389	CbGpPWpGaD
Levonorgestrel—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Levonorgestrel—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000252	0.00388	CbGpPWpGaD
Levonorgestrel—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.0011	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000251	0.00385	CbGpPWpGaD
Levonorgestrel—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.0011	CcSEcCtD
Levonorgestrel—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.0011	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.00025	0.00384	CbGpPWpGaD
Levonorgestrel—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00025	0.00384	CbGpPWpGaD
Levonorgestrel—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00109	CcSEcCtD
Levonorgestrel—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Levonorgestrel—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Levonorgestrel—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000248	0.0038	CbGpPWpGaD
Levonorgestrel—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00108	CcSEcCtD
Levonorgestrel—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00107	CcSEcCtD
Levonorgestrel—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00107	CcSEcCtD
Levonorgestrel—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00105	CcSEcCtD
Levonorgestrel—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00024	0.00369	CbGpPWpGaD
Levonorgestrel—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00105	CcSEcCtD
Levonorgestrel—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00105	CcSEcCtD
Levonorgestrel—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00104	CcSEcCtD
Levonorgestrel—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00104	CcSEcCtD
Levonorgestrel—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00103	CcSEcCtD
Levonorgestrel—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00103	CcSEcCtD
Levonorgestrel—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00103	CcSEcCtD
Levonorgestrel—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00101	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.000231	0.00355	CbGpPWpGaD
Levonorgestrel—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00101	CcSEcCtD
Levonorgestrel—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00101	CcSEcCtD
Levonorgestrel—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000227	0.000994	CcSEcCtD
Levonorgestrel—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.000994	CcSEcCtD
Levonorgestrel—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000226	0.000988	CcSEcCtD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.000225	0.00346	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000225	0.00345	CbGpPWpGaD
Levonorgestrel—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000979	CcSEcCtD
Levonorgestrel—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000978	CcSEcCtD
Levonorgestrel—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000974	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000221	0.0034	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.000962	CcSEcCtD
Levonorgestrel—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00022	0.000962	CcSEcCtD
Levonorgestrel—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.000957	CcSEcCtD
Levonorgestrel—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.000952	CcSEcCtD
Levonorgestrel—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000947	CcSEcCtD
Levonorgestrel—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000215	0.000942	CcSEcCtD
Levonorgestrel—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000939	CcSEcCtD
Levonorgestrel—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000933	CcSEcCtD
Levonorgestrel—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.000929	CcSEcCtD
Levonorgestrel—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000212	0.000929	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.00324	CbGpPWpGaD
Levonorgestrel—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00091	CcSEcCtD
Levonorgestrel—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00319	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000908	CcSEcCtD
Levonorgestrel—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000204	0.000894	CcSEcCtD
Levonorgestrel—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.000894	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000203	0.00312	CbGpPWpGaD
Levonorgestrel—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.000886	CcSEcCtD
Levonorgestrel—Rash—Formoterol—chronic obstructive pulmonary disease	0.000202	0.000886	CcSEcCtD
Levonorgestrel—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000202	0.000885	CcSEcCtD
Levonorgestrel—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.000885	CcSEcCtD
Levonorgestrel—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000885	CcSEcCtD
Levonorgestrel—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00088	CcSEcCtD
Levonorgestrel—Headache—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00088	CcSEcCtD
Levonorgestrel—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00088	CcSEcCtD
Levonorgestrel—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000878	CcSEcCtD
Levonorgestrel—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0002	0.000875	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.0002	0.00307	CbGpPWpGaD
Levonorgestrel—Rash—Montelukast—chronic obstructive pulmonary disease	0.000198	0.000868	CcSEcCtD
Levonorgestrel—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000198	0.000867	CcSEcCtD
Levonorgestrel—Depression—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000865	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000197	0.00303	CbGpPWpGaD
Levonorgestrel—Headache—Montelukast—chronic obstructive pulmonary disease	0.000197	0.000862	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000196	0.00301	CbGpPWpGaD
Levonorgestrel—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.000852	CcSEcCtD
Levonorgestrel—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.000844	CcSEcCtD
Levonorgestrel—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.000838	CcSEcCtD
Levonorgestrel—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.000837	CcSEcCtD
Levonorgestrel—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.000836	CcSEcCtD
Levonorgestrel—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.000836	CcSEcCtD
Levonorgestrel—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000191	0.000835	CcSEcCtD
Levonorgestrel—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.000835	CcSEcCtD
Levonorgestrel—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.000831	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000189	0.00291	CbGpPWpGaD
Levonorgestrel—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00082	CcSEcCtD
Levonorgestrel—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000187	0.000818	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000186	0.00286	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000184	0.00283	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000184	0.00283	CbGpPWpGaD
Levonorgestrel—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000805	CcSEcCtD
Levonorgestrel—Progesterone—CYP1A1—chronic obstructive pulmonary disease	0.000182	0.189	CrCbGaD
Levonorgestrel—SRD5A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00018	0.00277	CbGpPWpGaD
Levonorgestrel—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.000788	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00018	0.00276	CbGpPWpGaD
Levonorgestrel—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000784	CcSEcCtD
Levonorgestrel—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000782	CcSEcCtD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000178	0.00274	CbGpPWpGaD
Levonorgestrel—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000779	CcSEcCtD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000177	0.00272	CbGpPWpGaD
Levonorgestrel—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00271	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000176	0.0027	CbGpPWpGaD
Levonorgestrel—Progesterone—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.182	CrCbGaD
Levonorgestrel—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000765	CcSEcCtD
Levonorgestrel—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000761	CcSEcCtD
Levonorgestrel—Norethindrone—ALB—chronic obstructive pulmonary disease	0.000174	0.18	CrCbGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000173	0.00266	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000173	0.00266	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000173	0.00266	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000172	0.00264	CbGpPWpGaD
Levonorgestrel—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.178	CrCbGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000171	0.00263	CbGpPWpGaD
Levonorgestrel—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.000749	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.00017	0.00262	CbGpPWpGaD
Levonorgestrel—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000736	CcSEcCtD
Levonorgestrel—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000728	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000166	0.00255	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.00255	CbGpPWpGaD
Levonorgestrel—Methyltestosterone—ALB—chronic obstructive pulmonary disease	0.000165	0.171	CrCbGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000162	0.00249	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000161	0.00248	CbGpPWpGaD
Levonorgestrel—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000703	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000159	0.00245	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000159	0.00245	CbGpPWpGaD
Levonorgestrel—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000695	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000158	0.00243	CbGpPWpGaD
Levonorgestrel—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000688	CcSEcCtD
Levonorgestrel—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000688	CcSEcCtD
Levonorgestrel—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000682	CcSEcCtD
Levonorgestrel—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000678	CcSEcCtD
Levonorgestrel—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000678	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00235	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000152	0.00234	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00232	CbGpPWpGaD
Levonorgestrel—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000651	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000147	0.00226	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000147	0.00226	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000147	0.00225	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000147	0.00225	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000146	0.00224	CbGpPWpGaD
Levonorgestrel—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000626	CcSEcCtD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00219	CbGpPWpGaD
Levonorgestrel—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000619	CcSEcCtD
Levonorgestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00216	CbGpPWpGaD
Levonorgestrel—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000609	CcSEcCtD
Levonorgestrel—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000608	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000138	0.00213	CbGpPWpGaD
Levonorgestrel—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000605	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000136	0.0021	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000136	0.0021	CbGpPWpGaD
Levonorgestrel—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000596	CcSEcCtD
Levonorgestrel—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000585	CcSEcCtD
Levonorgestrel—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000577	CcSEcCtD
Levonorgestrel—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000575	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000573	CcSEcCtD
Levonorgestrel—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00057	CcSEcCtD
Levonorgestrel—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00197	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000561	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000127	0.00195	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	0.000127	0.00195	CbGpPWpGaD
Levonorgestrel—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000553	CcSEcCtD
Levonorgestrel—Infection—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000549	CcSEcCtD
Levonorgestrel—Shock—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000544	CcSEcCtD
Levonorgestrel—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000542	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	0.000124	0.0019	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000123	0.00189	CbGpPWpGaD
Levonorgestrel—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000537	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000535	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000121	0.00186	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	0.000121	0.00186	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000121	0.00186	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00185	CbGpPWpGaD
Levonorgestrel—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000527	CcSEcCtD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.00178	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000504	CcSEcCtD
Levonorgestrel—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000503	CcSEcCtD
Levonorgestrel—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.0005	CcSEcCtD
Levonorgestrel—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000487	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000111	0.0017	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000481	CcSEcCtD
Levonorgestrel—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.00048	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000479	CcSEcCtD
Levonorgestrel—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000477	CcSEcCtD
Levonorgestrel—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000477	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000109	0.00167	CbGpPWpGaD
Levonorgestrel—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000473	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000106	0.00163	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000104	0.00161	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000104	0.0016	CbGpPWpGaD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00159	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000452	CcSEcCtD
Levonorgestrel—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000452	CcSEcCtD
Levonorgestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00157	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000101	0.00155	CbGpPWpGaD
Levonorgestrel—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000439	CcSEcCtD
Levonorgestrel—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000437	CcSEcCtD
Levonorgestrel—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000437	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	9.96e-05	0.00153	CbGpPWpGaD
Levonorgestrel—Testosterone—ALB—chronic obstructive pulmonary disease	9.56e-05	0.0994	CrCbGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	9.35e-05	0.00144	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000408	CcSEcCtD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.25e-05	0.00142	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	9.11e-05	0.0014	CbGpPWpGaD
Levonorgestrel—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000397	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.01e-05	0.00138	CbGpPWpGaD
Levonorgestrel—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000391	CcSEcCtD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.78e-05	0.00135	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000378	CcSEcCtD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.41e-05	0.00129	CbGpPWpGaD
Levonorgestrel—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.000366	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	8.35e-05	0.00128	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.32e-05	0.00128	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.19e-05	0.00126	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.16e-05	0.00125	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.09e-05	0.00124	CbGpPWpGaD
Levonorgestrel—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000352	CcSEcCtD
Levonorgestrel—Rash—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000349	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000348	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.96e-05	0.00122	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	7.93e-05	0.00122	CbGpPWpGaD
Levonorgestrel—Headache—Prednisone—chronic obstructive pulmonary disease	7.91e-05	0.000346	CcSEcCtD
Levonorgestrel—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.88e-05	0.00121	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.84e-05	0.0012	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.72e-05	0.00119	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	7.67e-05	0.00118	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.66e-05	0.00118	CbGpPWpGaD
Levonorgestrel—Nausea—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000329	CcSEcCtD
Levonorgestrel—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.4e-05	0.00114	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.38e-05	0.00113	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.31e-05	0.00112	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	7.26e-05	0.00112	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.16e-05	0.0011	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	7.15e-05	0.0011	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.12e-05	0.00109	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.03e-05	0.00108	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.99e-05	0.00107	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.9e-05	0.00106	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.57e-05	0.00101	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.41e-05	0.000985	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	6.38e-05	0.00098	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.36e-05	0.000976	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.23e-05	0.000957	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.15e-05	0.000945	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.11e-05	0.000938	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.06e-05	0.000932	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.01e-05	0.000924	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.9e-05	0.000907	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.88e-05	0.000903	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.84e-05	0.000898	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.79e-05	0.00089	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.53e-05	0.00085	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.44e-05	0.000837	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.42e-05	0.000832	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.38e-05	0.000827	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.31e-05	0.000816	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.13e-05	0.000788	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.06e-05	0.000777	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.06e-05	0.000777	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	4.9e-05	0.000753	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.71e-05	0.000724	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.65e-05	0.000714	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.65e-05	0.000714	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.63e-05	0.000711	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.5e-05	0.000692	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.47e-05	0.000686	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.46e-05	0.000685	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.41e-05	0.000677	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.33e-05	0.000666	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.32e-05	0.000664	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.28e-05	0.000658	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	4.26e-05	0.000655	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.19e-05	0.000644	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.99e-05	0.000614	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.99e-05	0.000613	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.91e-05	0.000601	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.73e-05	0.000573	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.6e-05	0.000553	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.59e-05	0.000552	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.56e-05	0.000547	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.5e-05	0.000537	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.24e-05	0.000498	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.12e-05	0.000479	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3e-05	0.000462	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.96e-05	0.000455	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.9e-05	0.000445	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.76e-05	0.000424	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.73e-05	0.000419	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.66e-05	0.000409	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.62e-05	0.000402	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.54e-05	0.00039	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.38e-05	0.000366	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.34e-05	0.00036	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.32e-05	0.000356	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.27e-05	0.000349	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.17e-05	0.000334	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.15e-05	0.000331	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.09e-05	0.000321	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.05e-05	0.000315	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.000296	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.9e-05	0.000292	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.83e-05	0.000281	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.78e-05	0.000273	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.74e-05	0.000268	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.7e-05	0.000261	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.7e-05	0.000261	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.56e-05	0.00024	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.44e-05	0.000221	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.33e-05	0.000205	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000196	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000194	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000192	CbGpPWpGaD
Levonorgestrel—PGR—respiratory system—chronic obstructive pulmonary disease	1.22e-05	0.101	CbGeAlD
Levonorgestrel—SHBG—connective tissue—chronic obstructive pulmonary disease	1.19e-05	0.0985	CbGeAlD
Levonorgestrel—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.18e-05	0.000182	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000175	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.13e-05	0.000174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000166	CbGpPWpGaD
Levonorgestrel—PGR—connective tissue—chronic obstructive pulmonary disease	1.07e-05	0.0887	CbGeAlD
Levonorgestrel—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000162	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.02e-05	0.000157	CbGpPWpGaD
Levonorgestrel—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	9.82e-06	0.0812	CbGeAlD
Levonorgestrel—CYP19A1—connective tissue—chronic obstructive pulmonary disease	9.66e-06	0.0798	CbGeAlD
Levonorgestrel—ESR1—respiratory system—chronic obstructive pulmonary disease	9.54e-06	0.0788	CbGeAlD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.18e-06	0.000141	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.77e-06	0.000135	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.65e-06	0.000133	CbGpPWpGaD
Levonorgestrel—AR—connective tissue—chronic obstructive pulmonary disease	8.55e-06	0.0707	CbGeAlD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.42e-06	0.000129	CbGpPWpGaD
Levonorgestrel—ESR1—connective tissue—chronic obstructive pulmonary disease	8.4e-06	0.0694	CbGeAlD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.26e-06	0.000127	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.06e-06	0.000124	CbGpPWpGaD
Levonorgestrel—AR—bronchus—chronic obstructive pulmonary disease	8e-06	0.0661	CbGeAlD
Levonorgestrel—AR—smooth muscle tissue—chronic obstructive pulmonary disease	7.82e-06	0.0647	CbGeAlD
Levonorgestrel—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	7.68e-06	0.0635	CbGeAlD
Levonorgestrel—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.64e-06	0.000117	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.93e-06	0.000107	CbGpPWpGaD
Levonorgestrel—PGR—lung—chronic obstructive pulmonary disease	6.48e-06	0.0535	CbGeAlD
Levonorgestrel—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.35e-06	9.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.19e-06	7.98e-05	CbGpPWpGaD
Levonorgestrel—AR—lung—chronic obstructive pulmonary disease	5.16e-06	0.0426	CbGeAlD
Levonorgestrel—ESR1—lung—chronic obstructive pulmonary disease	5.07e-06	0.0419	CbGeAlD
Levonorgestrel—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.97e-06	7.63e-05	CbGpPWpGaD
